These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2177431)

  • 1. Tryptamine may couple dopaminergic and serotonergic transmission in the brain.
    Juorio AV; Paterson IA
    Gen Pharmacol; 1990; 21(5):613-6. PubMed ID: 2177431
    [No Abstract]   [Full Text] [Related]  

  • 2. Tryptamine: a neuromodulator or neurotransmitter in mammalian brain?
    Jones RS
    Prog Neurobiol; 1982; 19(1-2):117-39. PubMed ID: 6131482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoaminergic regulation of brain somatostatin metabolism in rats.
    Maeda K; Kakigi T; Kawata E; Kaneda H
    Jpn J Psychiatry Neurol; 1991 Mar; 45(1):109-10. PubMed ID: 1684392
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotonergic-dopaminergic interactions and extrapyramidal function.
    Chase TN
    Adv Biochem Psychopharmacol; 1974; 11(0):377-85. PubMed ID: 4367649
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serotoninergic systems and the problem of false transmitters].
    Roberge AG; Missala K; Sourkes TL
    Union Med Can; 1971 Mar; 100(3):475-9. PubMed ID: 4324484
    [No Abstract]   [Full Text] [Related]  

  • 6. Current trends in Australian neurology.
    Selby G
    Postgrad Med J; 1970 Apr; 46(534):191-9. PubMed ID: 4316785
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of long-term lithium treatment on reserpine-induced supersensitivity in dopaminergic and serotonergic transmission.
    Friedman E; Dallob A; Levine G
    Life Sci; 1979 Oct; 25(14):1263-6. PubMed ID: 229375
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional interaction between serotonin-S2 and dopamine-D2 neurotransmission as revealed by selective antagonism of hyper-reactivity to tryptamine and apomorphine.
    Awouters F; Niemegeers CJ; Megens AA; Janssen PA
    J Pharmacol Exp Ther; 1990 Sep; 254(3):945-51. PubMed ID: 1697623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine-dopaminergic interaction data.
    Beasley CM
    J Clin Psychiatry; 1994 Feb; 55(2):77-9. PubMed ID: 8077159
    [No Abstract]   [Full Text] [Related]  

  • 10. The behavioural effects of intravenously administered tryptamine in mice.
    Yamada J; Sugimoto Y; Horisaka K
    Neuropharmacology; 1987 Jan; 26(1):49-53. PubMed ID: 3561719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tryptamine as an endogenous modulator of neuronal sensitivity to serotonin].
    Komissarov IV; Abramets II; Samoĭlovich IM
    Neirofiziologiia; 1989; 21(3):352-7. PubMed ID: 2770917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.
    Seger D
    Clin Toxicol (Phila); 2010 Aug; 48(7):695-708. PubMed ID: 20849328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents.
    Millan MJ; Lejeune F; Gobert A
    J Psychopharmacol; 2000 Jun; 14(2):114-38. PubMed ID: 10890307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrahydrobiopterin and dopamine release.
    Watanabe Y; Mataga N; Imamura K; Onoe H; Koshimura K; Miwa S; Hartvig P; Tedroff J; Bjurling P; Långström B
    Jpn J Psychiatry Neurol; 1991 Jun; 45(2):513-4. PubMed ID: 1684829
    [No Abstract]   [Full Text] [Related]  

  • 15. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.
    Miczek KA; Fish EW; De Bold JF; De Almeida RM
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic and serotonergic receptor function in the CNS.
    Keltner NL; Hogan B; Guy DM
    Perspect Psychiatr Care; 2001; 37(2):65-8. PubMed ID: 15521304
    [No Abstract]   [Full Text] [Related]  

  • 17. Serotonin and drug-induced movement disorders.
    Sachdev P
    Aust N Z J Psychiatry; 1994 Dec; 28(4):695-6. PubMed ID: 7794217
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurobiological aspects of social anxiety disorder.
    Furmark T
    Isr J Psychiatry Relat Sci; 2009; 46(1):5-12. PubMed ID: 19728568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
    Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Structural and functional organization of the cerebral dopaminergic system].
    Barishpolets VV; Fedotova IuO; Sapronov NS
    Eksp Klin Farmakol; 2009; 72(3):44-9. PubMed ID: 19642593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.